MLchartDataset catalogue

lonafarnib

Term · Oncology and biomedicine · MLC-T-ONC-004921

  1. An anticancer drug that belongs to the family of drugs called enzyme inhibitors. Also called SCH 66336.

  2. A synthetic tricyclic derivative of carboxamide with antineoplastic properties. Lonarfanib binds to and inhibits farnesyl transferase, an enzyme involved in the post-translational modification and activation of Ras proteins. Ras proteins participate in numerous signalling pathways (proliferation, cytoskeletal organization), and play an important role in oncogenesis. Mutated ras proteins have been found in a wide range of human cancers.

Table 1. Record
IdentifierMLC-T-ONC-004921
FieldOncology and biomedicine
SynonymsSCH 66336
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-004921",
  "term": "lonafarnib",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An anticancer drug that belongs to the family of drugs called enzyme inhibitors. Also called SCH 66336.",
    "A synthetic tricyclic derivative of carboxamide with antineoplastic properties. Lonarfanib binds to and inhibits farnesyl transferase, an enzyme involved in the post-translational modification and activation of Ras proteins. Ras proteins participate in numerous signalling pathways (proliferation, cytoskeletal organization), and play an important role in oncogenesis. Mutated ras proteins have been found in a wide range of human cancers."
  ],
  "synonyms": [
    "SCH 66336"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/lonafarnib/"
}

Record 10,289 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.